April 19, 2010 - MicroLight Corporation of America : laser treats fibromyalgia - Fibromyalgia is a condition in which the brain processes pain in an abnormal way, resulting in chronic, widespread muscular-skeletal pain and chronic fatigue. This condition effects millions of Americans and has been poorly understood and under diagnosed, resulting in billions of dollars in cost to our health care system. In the past, treatments have been primarily with medications; often side effects can make the symptoms worse.
The LOW LEVEL LASER used is the Patented ML830® which was the first “low level Laser” approved by the FDA in 2002 to treat pain and swelling. The Laser produces no heat to the tissue and causes vassal dilation in the Micro Capillary bed, the treatment is PAINLESS WITH NO SIDE EFFECTS... MicroLight Corporation of America's Press Release -
Blog Archive
-
▼
2010
(38)
-
▼
April
(11)
- MicroLight : laser treats fibromyalgia
- Ferring Pharmaceuticals : Wake Up to Nocturia - St...
- Cephalon : Complete Response Letter for NUVIGIL fo...
- Arena Pharmaceuticals : Initiation of Phase 1 Clin...
- SOMAXON : FDA APPROVAL OF SILENOR® (DOXEPIN) FOR ...
- GE’s Virtual Sleep Lab Enables Sleep Apnea Testing...
- ImThera Medical Successfully Implants First Patien...
- Lupin : FDA tentative approval for Eszopiclone tab...
- Vantia Therapeutics' lead candidate VA106483 enter...
- ResMed : Next-Generation CPAP Series in Europe
- Apnex Medical : Additional $14 Million
-
▼
April
(11)